PURPOSE: Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (AnaConDa), in comparison with propofol and remifentanil. METHODS: Seventeen patients undergoing mechanical ventilation underwent sedation with sevoflurane delivered with AnaConDa (phase SevAn), preceded and followed by sedation with propofol and remifentanil (phases ProRe(1), ProRe(2)), with the same sedation targets. RESULTS: With both strategies it was possible to achieve the sedation targets. Time required to sedate and awake patients was greater during SevAn than ProRe(1): respectively, 3.3 +/- 3.0 versus 8.9 +/- 6.1 and 7.47 +/- 5.05 versus 16.3 +/- 11.4 min. During SevAn the PaCO(2) and minute ventilation increased. Hemodynamics was stable between ProRe(1) and SevAn, except for an increase in heart rate in the SevAn phase. Environmental pollution from sevoflurane was within the safety limits. CONCLUSIONS: Sevoflurane can be effectively and safely used for short-term sedation of ICU patients with stable hemodynamic conditions.
PURPOSE: Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (AnaConDa), in comparison with propofol and remifentanil. METHODS: Seventeen patients undergoing mechanical ventilation underwent sedation with sevoflurane delivered with AnaConDa (phase SevAn), preceded and followed by sedation with propofol and remifentanil (phases ProRe(1), ProRe(2)), with the same sedation targets. RESULTS: With both strategies it was possible to achieve the sedation targets. Time required to sedate and awake patients was greater during SevAn than ProRe(1): respectively, 3.3 +/- 3.0 versus 8.9 +/- 6.1 and 7.47 +/- 5.05 versus 16.3 +/- 11.4 min. During SevAn the PaCO(2) and minute ventilation increased. Hemodynamics was stable between ProRe(1) and SevAn, except for an increase in heart rate in the SevAn phase. Environmental pollution from sevoflurane was within the safety limits. CONCLUSIONS:Sevoflurane can be effectively and safely used for short-term sedation of ICU patients with stable hemodynamic conditions.
Authors: Javier F Belda; Marina Soro; Rafael Badenes; Andreas Meiser; María Luisa García; Gerardo Aguilar; Francisco J Martí Journal: Anesth Analg Date: 2008-04 Impact factor: 5.108
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: Kerstin D Röhm; Michael W Wolf; Thilo Schöllhorn; Alexander Schellhaass; Joachim Boldt; Swen N Piper Journal: Intensive Care Med Date: 2008-05-24 Impact factor: 17.440
Authors: T P Malan; J A DiNardo; R J Isner; E J Frink; M Goldberg; P E Fenster; E A Brown; R Depa; L C Hammond; H Mata Journal: Anesthesiology Date: 1995-11 Impact factor: 7.892
Authors: Elena Spinelli; Tommaso Mauri; Jeremy R Beitler; Antonio Pesenti; Daniel Brodie Journal: Intensive Care Med Date: 2020-02-03 Impact factor: 17.440
Authors: Giacomo Grasselli; Marco Giani; Vittorio Scaravilli; Benedetta Fumagalli; Carminia Mariani; Sara Redaelli; Alberto Lucchini; Alberto Zanella; Nicolò Patroniti; Antonio Pesenti; Giuseppe Foti Journal: Crit Care Explor Date: 2021-01-08
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2010-01-28 Impact factor: 17.440